Gut microbiome features associate with immune checkpoint inhibitor response in individuals with non-melanoma skin cancers: an exploratory study
ABSTRACT Immune checkpoint inhibitor (ICI) therapy has yielded revolutionary outcomes among some individuals with skin cancer, but a large percentage of individuals do not benefit from these treatments. The gut microbiota is hypothesized to impact ICI therapy outcomes. However, data on ICI therapy,...
Saved in:
| Main Authors: | Yujie Zhao, Jacqueline T. Ferri, James R. White, Megan D. Schollenberger, Kim Peloza, Cynthia L. Sears, Evan J. Lipson, Fyza Y. Shaikh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Society for Microbiology
2025-03-01
|
| Series: | Microbiology Spectrum |
| Subjects: | |
| Online Access: | https://journals.asm.org/doi/10.1128/spectrum.02559-24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diversity Gaps in Clinical Practice Guidelines for Cutaneous Malignancies: A Focus on Melanoma, Basal Cell Carcinoma, and Squamous Cell Carcinoma
by: Courtney Chau, et al.
Published: (2025-04-01) -
CD30+ lymphoproliferative disorder following immune checkpoint inhibition in a patient with Merkel cell carcinoma
by: Aneri Bhargav Patel, BS, et al.
Published: (2025-08-01) -
Primary Merkel cell carcinoma of the salivary gland: a clinicopathologic study of four cases with a review of literature
by: Gyuheon Choi, et al.
Published: (2025-05-01) -
Delta-catenin is required for cell proliferation in virus-positive Merkel cell carcinoma cell lines but not in human fibroblasts
by: Joselyn Landazuri Vinueza, et al.
Published: (2025-06-01) -
Ontogenisis of Merkel-cell carcinoma
by: Fernanda Guimarães Souza, et al.
Published: (2025-04-01)